title: Targeting chemokine receptors for HIV: past, present and future.
authors.affiliation: Biopharma, 13 Glenwood Lane, North Grafton, MA 01536, USA.
authors.forename: Simon P
authors.initials: SP
authors.lastname: Fricker
mesh_terms: D019380:Anti-HIV Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D065100:CCR5 Receptor Antagonists / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1 / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D019713:Receptors, CCR5 / Q000737:chemistry / Q000378:metabolism; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors / Q000378:metabolism; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D019380:Anti-HIV Agents; D065100:CCR5 Receptor Antagonists; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D019707:Receptors, Chemokine
keywords: CCR5; CXCR4; HIV; chemokine receptor; maraviroc; plerixafor